| 缩写名/全名 |
PAK J PHARM SCI
Pakistan Journal of Pharmaceutical Sciences |
||||||||||||||||
| ISSN号 | 1011-601X | ||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||
| 影响因子 | 2015:0.581, 2016:0.649, 2017:0.804, 2018:0.596, 2019:0.562, | ||||||||||||||||
| 出版国家 | PAKISTAN | ||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||
| 年文章数 | 402 | ||||||||||||||||
| 出版年份 | 1988 | ||||||||||||||||
| 是否OA | No | ||||||||||||||||
| 审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||
| 录用比例 | 容易 | ||||||||||||||||
| 投稿链接 | http://www.pjps.pk/?page_id=18 | ||||||||||||||||
| 投稿官网 | http://www.pjps.pk/ | ||||||||||||||||
| h-index | 35 | ||||||||||||||||
| CiteScore |
|
||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1011-601X%5BISSN%5D | ||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Monoamine oxidase inhibitors protect against coronary heart disease in rodent rat models: A pilot study. Author: Shao W1, Shu S2, Liu R3, Jiang Y1, Zhang W1, Men H1. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):371-375. PubMed |
| 2. | Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine. Author: Tian W1, Qiu Z2, Cui Y2, Zhang J2, Ma X2, Cui S2, Zheng S3. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):377-382. PubMed |
| 3. | Hypolipidemic and antioxidant activities of volatile oils from fresh leaves of Michelia martini Levl. Author: Ling-Hua L1, Jing H2, Hai-Yan L2, Yan-Hua C3, Xiao-Ying Y4, Zhi-Ping G2. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):383-389. PubMed |
| 4. | Pharmacological mechanism and apoptosis effect of baicalein in protecting myocardial ischemia reperfusion injury in rats. Author: Jie Z1, Xiujian W2, Jin L3. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):407-412. PubMed |
| 5. | Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing. Author: Liantao Z1, Jing Z2, Lingling L3, Hua L4. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):413-419. PubMed |
| 6. | Clinical effect of mifepristone on patients with ovarian cancer in pregnancy. Author: Shang L1, Wang Y2, Lyu Y3. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):421-426. PubMed |
| 7. | Adverse reactions of fluoroquinolones to central nervous system and rational drug use in nursing care. Author: Haiping L1, Ziqiang J2, Qina Z1, Yuhua D3. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):427-432. PubMed |
| 8. | Clinical effect of the extract of TCM Fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease. Author: Hongguang J1, Xingjie H1, Mingliang J1, Yun L1, Tongjian L, Jingmo Y1, Liang L1, Lifang Z1. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):433-437. PubMed |
| 9. | Clinical efficacy of celecoxib for osteoarthritis and bone anchor assisted knee extensor reconstruction. Author: Cai G1, Li Y1, I Han R2, Wang F1, Wang G1, He C1, Jia D1, Wang K1, Ma W3, Xiao C4, Song E1, Chen G1, Yu Y1. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):439-444. PubMed |
| 10. | Complex carotid artery stenosis via enhanced anterior cervical triangle posterior vena jugularisinterna approach. Author: Wang M1, Li G1, Sui S1, Cao S1, Gai X1, Zhu J1, Chao Li CL1. Journal: Pak J Pharm Sci. 2019 Jan;32(1(Special)):453-457. PubMed |
|
|
